series-b
Stage
1
Investors
About
StrandTx is a clinical-stage biotechnology company developing proprietary mRNA therapeutics focused on cancer and autoimmune diseases by advancing targeted, safe, and potent lipid nanoparticle delivery and RNA engineering technologies.
Explore StrandTx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.